Publication date	Issuer	Person discharging managerial responsibilities	Position	Closely associated	Nature of transaction	Instrument name	Intrument type	ISIN	Transaction date	Volume	Unit	Price	Currency	Status	Details
26/05/2022	Xvivo Perfusion Aktiebolag	Dag Andersson Tilk	Chief Executive Officer (CEO)/Managing Directory		Disposal	XVIVO 2020/2022	Subcription warrant		24/05/2022	26,583	Quantity	41.95	SEK	History	Notification
26/05/2022	Xvivo Perfusion Aktiebolag	Dag Andersson Tilk	Chief Executive Officer (CEO)/Managing Directory		Exercise decrease	XVIVO 2020/2022	Subcription warrant		24/05/2022	5,417	Quantity	0.00	SEK	History	Notification
26/05/2022	Xvivo Perfusion Aktiebolag	Dag Andersson Tilk	Chief Executive Officer (CEO)/Managing Directory		Exercise increase	Xvivo Perfusion AB	Share	SE0004840718	24/05/2022	5,417	Quantity	205.88	SEK	History	Notification
25/05/2022	Xvivo Perfusion Aktiebolag	Kristoffer Nordström	Chief Financial Officer (CFO)		Disposal	XVIVO 2020/2022	Subcription warrant		24/05/2022	6,646	Quantity	41.95	SEK	History	Notification
25/05/2022	Xvivo Perfusion Aktiebolag	Kristoffer Nordström	Chief Financial Officer (CFO)		Exercise decrease	XVIVO 2020/2022	Subcription warrant		24/05/2022	1,354	Quantity	0.00	SEK	History	Notification
25/05/2022	Xvivo Perfusion Aktiebolag	Kristoffer Nordström	Chief Financial Officer (CFO)		Exercise increase	Xvivo Perfusion AB	Share	SE0004840718	24/05/2022	1,354	Quantity	205.88	SEK	History	Notification
25/05/2022	Xvivo Perfusion Aktiebolag	Christoffer Björn Rosenblad	Deputy CEO/Deputy Managing Director		Disposal	XVIVO 2020/2022	Subcription warrant		24/05/2022	13,292	Quantity	41.95	SEK		Notification
25/05/2022	Xvivo Perfusion Aktiebolag	Christoffer Björn Rosenblad	Deputy CEO/Deputy Managing Director		Exercise decrease	XVIVO 2020/2022	Subcription warrant		24/05/2022	2,708	Quantity	0.00	SEK		Notification
25/05/2022	Xvivo Perfusion Aktiebolag	Christoffer Björn Rosenblad	Deputy CEO/Deputy Managing Director		Exercise increase	Xvivo Perfusion AB	Share	SE0004840718	24/05/2022	2,708	Quantity	205.88	SEK		Notification
25/05/2022	Xvivo Perfusion Aktiebolag	Dag Andersson Tilk	Chief Executive Officer (CEO)/Managing Directory		Disposal	XVIVO 2020/2022	Subcription warrant		24/05/2022	26,583	Quantity	41.95	SEK	Revised	Notification